Expand this Topic clickable element to expand a topic
Skip to content
Optica Publishing Group

Multi-agent fluorescence imaging for quantitative assessment of tumor biomarkers

Open Access Open Access

Abstract

Quantitative molecular imaging of tumor biomarkers in vivo remains elusive due to the confounding effects of non-specific uptake. A multi-agent fluorescence tomography approach enables receptor concentration estimation in vivo, facilitating the study of drug-receptor interactions.

© 2016 Optical Society of America

PDF Article
More Like This
CT Tumor Sizing as a Quantitative Imaging Biomarker: When is Bias Relevant?

Nicholas Petrick, Rongping Zeng, Marios A Gavrielides, Qin Li, Berkman Sahiner, and Kyle J. Myers
QW1G.1 Quantitative Medical Imaging (QMI) 2013

Bioactive peptide-fluorescent dye conjugates for in vivo tumor imaging

Samuel Achilefu, Joseph E. Bugaj, Richard B. Dorshow, and Raghavan Rajagopalan
MD6 Biomedical Optical Spectroscopy and Diagnostics (BIOMED) 2000

Longitudinal Volumetric Assessment of Glioblastoma Brain Tumors in 3D Bio-Printed Environment by Mesoscopic Fluorescence Molecular Tomography

Mehmet S. Ozturk, Vivian K. Lee, Guohao Dai, and Xavier Intes
JM3A.46 Cancer Imaging and Therapy (Cancer) 2016

Select as filters


Select Topics Cancel
© Copyright 2024 | Optica Publishing Group. All Rights Reserved